Dr. García Prado, leader of the Viral Immune Evasion and Vacciones (VIRIEVAC) at the IrsiCaixa AIDS Research Institute will combine the new position with the leadership of her group, focused on the design of new strategies against HIV. Manel Puig, General Director of the IGTP, has presented the new organizational chart during the presentation of the Research Agenda 2018, together with the new challenges for the coming years.
At the IGTP TODAY
Tanya Vavouri, researcher at the IGTP and Josep Carreras Leukemia Research Institute is one of the nominees for the Vanguardia de la Ciencia award, for the study showing that environment affects genetics and can be retained for generations. The vote is open to everyone, scientist or not, until February 28.
The IGTP leads the biological and pathological studies in an international clinical trial focused on child and adolescent liver tumours
It is the first and largest international clinical trial ever in this type of patients. IGTP researchers coordinate what is going to be a unique collection in Europe of biological samples for this segment of patients, and will lead the posterior studies. Liver cancer in children is classified as a rare diseases and, in Spain, 15 cases are diagnoses every year.
The spin-off is the result of a joint research project between the IGTP, ICN2 and ICREA and has already attracted 1.1 million euros. The Catalan biotech company has been created to develop the therapies for clinical use. The therapy uses liposomes to halt the destructive reaction of the body's own tissues caused by diseases such as Type 1 diabetes or multiple sclerosis.
The spin-off company Swan Medical SL, of which the IGTP is a shareholder, is responsible for production and distribution of the product, baptised Rutilight®, that can be adapted to all current surgical instruments to provide a spotlight on the operating area. The new device eliminates shadows in the operating area and illuminates places that are difficult to access. The tool has been invented by surgeons for surgeons
Examination of skin plaques by a paediatric dermatologist has been confirmed as a reliable way to diagnose NF2 in children before symptoms appear
IGTP Scientists working with the Reference Centre for Phakomatoses in the Germans Trias i Pujol Hospital-ICO Badalona have confirmed what dermatologists on the team have long suspected. Skin plaques in young children can be used to identify NF2 patients long before their symptoms appear.
The IGTP research group for Innovation in respiratory infections and tuberculosis diagnosis has taken part in the 2017 edition of IDEA2 Global, a mentoring programme of MIT (Massachusetts Institute of Technology) to encourage innovative ideas in health and help to convert them into transferable projects from the point of view both of applications in health and of business.
Researchers find a novel mechanism to decrease inflammation and promote tissue regeneration after a heart attack
Researchers from the Germans Trias i Pujol Research Institute (IGTP) have described a new mechanism of mesenychymal stem cells for the modulation of the immune response seen in vitro and in a translational model for heart attack in pigs.
A trial in advanced colorectal cancer opens the door to a future blood test to predict the most efficient treatment for reducing metastasis
The study, published in 'Annals of Oncology' aimed to demonstrate that choosing the treatment regime based on genetic variants could improve the prognosis of patients with advanced colorectal cancer. Although this primary objective was not achieved, the trial did show that a blood test can be used to predict the most efficient treatment to reduce metastasis.
La 6a edició del programa Talents lliura les beques d’enguany i estrena ajuts per a la intensificació de recerca
Aquest dimecres dia 29 s'han lliurat els ajuts del Programa Talents de la Fundació Catalunya-La Pedrera i l'Hospital Germans Trias i Pujol. La 6a edició del programa premia 9 professionals de l'hospital Germans Trias i 4 d'Atenció Primària per fer recerca a l'IGTP i, a més, s'amplia amb les beques Germans Trias Sapiens, per a la intensificació de recerca a professionals de l'Hospital.